Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa

Nav

General Info

Email
Print

Geography

Angola (AGO)

Benin (BEN)

Botswana (BWA)

Burkina Faso (BFA)

Burundi (BDI)

Cabo Verde (CPV)

Cameroon (CMR)

Central African Republic (CAF)

Chad (TCD)

Comoros (COM)

Congo (COG)

Côte d'Ivoire (CIV)

Democratic Republic of the Congo (COD)

Djibouti (DJI)

Equatorial Guinea (GNQ)

Eritrea (ERI)

Ethiopia (ETH)

Gabon (GAB)

Gambia (GMB)

Ghana (GHA)

Guinea (GIN)

Guinea-Bissau (GNB)

Kenya (KEN)

Lesotho (LSO)

Liberia (LBR)

Madagascar (MDG)

Malawi (MWI)

Mali (MLI)

Mauritania (MRT)

Mauritius (MUS)

Mozambique (MOZ)

Namibia (NAM)

Niger (NER)

Nigeria (NGA)

Rwanda (RWA)

Sao Tome and Principe (STP)

Senegal (SEN)

Seychelles (SYC)

Sierra Leone (SLE)

Somalia (SOM)

South Africa (ZAF)

Sudan (SDN)

Eswatini (SWZ)

Togo (TGO)

Uganda (UGA)

United Republic of Tanzania (TZA)

Zambia (ZMB)

Zimbabwe (ZWE)

View all

Time period covered

01/2010 - 12/2012

Data type

Scientific literature

Keywords

Cancers, Cervix uteri cancer, HPV, HPV vaccines, Incidence, Preventive interventions

Citation

Authors

Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I

Journal

Vaccine

Volume

31 Suppl 5

Pages

F60-72

Publication year

2013

Suggested citation

Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa. Vaccine. 2013; 31 Suppl 5: F60-72.

DOI

10.1016/j.vaccine.2012.07.093

PMID

24331749

GHDx Entry last modified on: Jan 31, 2023